These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 17960969

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic variability of quetiapine and the active metabolite N-desalkylquetiapine in psychiatric patients.
    Bakken GV, Rudberg I, Molden E, Refsum H, Hermann M.
    Ther Drug Monit; 2011 Apr; 33(2):222-6. PubMed ID: 21383647
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets.
    Hole K, Lorentsen SK, Nordby KL, Slettvik M, Sørum IT, Molden E, Haslemo T.
    Eur J Clin Pharmacol; 2024 Jun; 80(6):839-845. PubMed ID: 38396309
    [Abstract] [Full Text] [Related]

  • 5. Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations.
    Aichhorn W, Marksteiner J, Walch T, Zernig G, Saria A, Kemmler G.
    Int Clin Psychopharmacol; 2006 Mar; 21(2):81-5. PubMed ID: 16421458
    [Abstract] [Full Text] [Related]

  • 6. Relationship Between Daily Dose, Serum Concentration, and Clinical Response to Quetiapine in Children and Adolescents with Psychotic and Mood Disorders.
    Albantakis L, Egberts K, Burger R, Kulpok C, Mehler-Wex C, Taurines R, Unterecker S, Wewetzer C, Romanos M, Gerlach M.
    Pharmacopsychiatry; 2017 Nov; 50(6):248-255. PubMed ID: 28561203
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quetiapine serum concentrations in psychiatric patients: the influence of comedication.
    Hasselstrøm J, Linnet K.
    Ther Drug Monit; 2004 Oct; 26(5):486-91. PubMed ID: 15385830
    [Abstract] [Full Text] [Related]

  • 10. Steady-state pharmacokinetic, safety, and tolerability profiles of quetiapine, norquetiapine, and other quetiapine metabolites in pediatric and adult patients with psychotic disorders.
    Winter HR, Earley WR, Hamer-Maansson JE, Davis PC, Smith MA.
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):81-98. PubMed ID: 18294091
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Individual clearance and therapeutic drug monitoring of quetiapine in clinical practice.
    Wittmann M, Hausner H, Köstlbacher A, Hajak G, Haen E.
    Neuro Endocrinol Lett; 2010 Feb; 31(2):203-7. PubMed ID: 20424588
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of quetiapine in elderly patients with selected psychotic disorders.
    Jaskiw GE, Thyrum PT, Fuller MA, Arvanitis LA, Yeh C.
    Clin Pharmacokinet; 2004 Feb; 43(14):1025-35. PubMed ID: 15530131
    [Abstract] [Full Text] [Related]

  • 18. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine.
    Seeman P, Tallerico T.
    Am J Psychiatry; 1999 Jun; 156(6):876-84. PubMed ID: 10360126
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Determining serum concentrations of the modern antipsychotic quetiapin: clinical relevance in therapeutic drug monitoring].
    Köhnlein O, Lutz R, Schmauss M, Messer T.
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S175-7. PubMed ID: 15570545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.